arrow
J

Judith R. Kroep

leiden university medical center
H指数:59
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PARP-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional HRD testing

利用循环肿瘤DNA和功能性HRD检测评估复发性上皮性卵巢癌的PARP抑制剂应答

2026-10-010
OA
No Prognostic Role for FIGO grading in Mismatch Repair Deficient Endometrial Carcinoma

错配修复缺陷型子宫内膜癌中FIGO分级无预后作用

2026-06-130
OAAI
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial

POSITIVE试验(女性内分泌敏感性乳腺癌中断治疗的妊娠结局与安全性)最新结果

2026-05-280
PRE
Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling

细胞周期阻滞通过增强葡萄糖代谢和IL-2信号增强CD8 T细胞效应子功能

2026-01-190
OAAI
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer

患者对高危子宫内膜癌辅助化疗偏好的年龄相关差异

2025-12-020
OAAI
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误:“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

2025-09-220
PREAI
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

一种用于预测高级别浆液性卵巢癌患者对铂类为基础疗法临床反应的离体3D微肿瘤检测平台

2025-08-300
OAAI
Progression free survival as a surrogate of overall survival in metastatic or recurrent endometrial cancer: an EORTC Gynaecologic Cancer Group study

无进展生存期作为晚期或复发性子宫内膜癌总生存期的替代指标:一项EORTC妇科肿瘤组研究

2025-08-190
PRE
Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy

接受初始化放疗的宫颈癌女性患者骨髓脂肪分数和免疫细胞计数的变化

2025-08-090
OAAI
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中,预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

2025-07-260
OAAI
Uterine Leiomyosarcoma

子宫平滑肌肉瘤

2025-06-300
PRE
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept study

APOLLO:原发性外阴鳞状细胞癌的新辅助帕博利珠单抗治疗——一项多中心、单臂、II期概念验证临床研究

2025-04-170
OAAI
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial
2025-02-010
OAAI